Ph.D. Kiernan Seth - VP, Chief Commercial Officer at LEXICON PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
VP, Chief Commercial Officer
Issuer Symbol
LXRX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ph.D. Kiernan Seth since 27 Jan 2025

Holdings reported by Ph.D. Kiernan Seth for LEXICON PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 53,136 $55,968 $1.05 28 Feb 2023 Direct
Restricted Stock Units 45,927 $48,375 $1.05 28 Feb 2023 Direct Common Stock
Stock Option (Right to Buy) 280,100 09 Feb 2023 Direct Common Stock

Transactions reported by Ph.D. Kiernan Seth for LEXICON PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.